ArticleMethodsX2025
EyeMap: A fusion-based method for eye movement-based visual attention maps as predictive markers of parkinsonism.
Article in MethodsX, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
EyeMap is a method for visualizing and classifying eye movement patterns using scanpaths, fixation heatmaps, and gridded Areas of Interest (AOIs). EyeMap combines predictions from modality-specific machine learning and deep learning models using a late-fusion technique to produce interpretable gaze representations. By collecting spatial, temporal, and regional elements of gaze data, the method enhances diagnostic interpretability and enables the detection of Parkinsonian symptoms. This method provides complementary perspectives on gaze behavior, encompassing spatial focus, temporal scan order, and attention allocation across regions of interest. A dataset consisting of visualizations of organized visual tasks completed by both PD patients and healthy controls is created to support the development and validation of this method. EyeMap shows that vision-driven models may detect PD-specific gaze anomalies without the need for manual feature engineering. All implementation steps, from data acquisition to model fusion, are fully described to enable reproducibility and potential adaptation to other gaze-based analysis contexts.1.A structured method was developed to visualize eye-tracking data in three distinct formats2.Classification outputs from separate gaze visualizations were combined using softmax-level fusion3.A new eye-tracking dataset was generated to support method development and reproducibility.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.